Works matching IS 03065251 AND DT 1981 AND VI 11 AND IP 3
1
- British Journal of Clinical Pharmacology, 1981, v. 11, n. 3, p. 255, doi. 10.1111/j.1365-2125.1981.tb00530.x
- Orr, MW;
- Knox, JM;
- Allen, R;
- Gelder, MG;
- Grahame-Smith, DG
- Article
2
- British Journal of Clinical Pharmacology, 1981, v. 11, n. 3, p. 309, doi. 10.1111/j.1365-2125.1981.tb00541.x
- Hughes, RJ;
- James, IM;
- Djiane, A
- Article
3
- British Journal of Clinical Pharmacology, 1981, v. 11, n. 3, p. 275, doi. 10.1111/j.1365-2125.1981.tb00534.x
- Back, DJ;
- Bates, M;
- Breckenridge, AM;
- Ellis, A;
- Hall, JM;
- Maciver, M;
- Orme, ML;
- Rowe, PH
- Article
4
- British Journal of Clinical Pharmacology, 1981, v. 11, n. 3, p. 237, doi. 10.1111/j.1365-2125.1981.tb00527.x
- Article
5
- British Journal of Clinical Pharmacology, 1981, v. 11, n. 3, p. 303, doi. 10.1111/j.1365-2125.1981.tb00538.x
- McAllister, WA;
- Mitchell, DM;
- Collins, JV
- Article
6
- British Journal of Clinical Pharmacology, 1981, v. 11, n. 3, p. 307, doi. 10.1111/j.1365-2125.1981.tb00540.x
- Parratt, JR;
- Mackenzie, JE
- Article
7
- 1981
- Aslaksen, A;
- Bakke, OM;
- Vigander, T
- Other
8
- British Journal of Clinical Pharmacology, 1981, v. 11, n. 3, p. 314, doi. 10.1111/j.1365-2125.1981.tb00544.x
- Barbieri, C;
- Caldara, R;
- Ferrari, C
- Article
9
- British Journal of Clinical Pharmacology, 1981, v. 11, n. 3, p. 225, doi. 10.1111/j.1365-2125.1981.tb00526.x
- Article
10
- British Journal of Clinical Pharmacology, 1981, v. 11, n. 3, p. 295, doi. 10.1111/j.1365-2125.1981.tb00537.x
- Whiting, B;
- Williams, RL;
- Lorenzi, M;
- Varady, JC;
- Robins, DS
- Article
11
- British Journal of Clinical Pharmacology, 1981, v. 11, n. 3, p. 265, doi. 10.1111/j.1365-2125.1981.tb00532.x
- Dalal, JJ;
- Ross, PJ;
- Wong, K;
- Sheridan, DJ;
- Ruttley, MS;
- Lewis, MJ;
- Henderson, AH
- Article
12
- British Journal of Clinical Pharmacology, 1981, v. 11, n. 3, p. 312, doi. 10.1111/j.1365-2125.1981.tb00543.x
- Ha, HR;
- Kewitz, G;
- Wenk, M;
- Follath, F
- Article
13
- British Journal of Clinical Pharmacology, 1981, v. 11, n. 3, p. 287, doi. 10.1111/j.1365-2125.1981.tb00536.x
- Quarterman, CP;
- Kendall, MJ;
- Jack, DB
- Article
14
- British Journal of Clinical Pharmacology, 1981, v. 11, n. 3, p. 251, doi. 10.1111/j.1365-2125.1981.tb00529.x
- Sheth, UK;
- Valame, SP;
- Gupta, KC;
- Baxi, AJ;
- Kulkarni, VN;
- Pispati, PK
- Article
15
- British Journal of Clinical Pharmacology, 1981, v. 11, n. 3, p. 261, doi. 10.1111/j.1365-2125.1981.tb00531.x
- Knox, JM;
- Orr, MW;
- Allen, R;
- Gelder, MG;
- Grahame-Smith, DG
- Article
16
- British Journal of Clinical Pharmacology, 1981, v. 11, n. 3, p. 310, doi. 10.1111/j.1365-2125.1981.tb00542.x
- Maidment, CG;
- Hughes, RD;
- James, IM
- Article
17
- British Journal of Clinical Pharmacology, 1981, v. 11, n. 3, p. 279, doi. 10.1111/j.1365-2125.1981.tb00535.x
- Aitio, ML;
- Mansury, L;
- Tala, E;
- Haataja, M;
- Aitio, A
- Article
18
- British Journal of Clinical Pharmacology, 1981, v. 11, n. 3, p. 245, doi. 10.1111/j.1365-2125.1981.tb00528.x
- Routledge, PA;
- Stargel, WW;
- Kitchell, BB;
- Barchowsky, A;
- Shand, DG
- Article
19
- British Journal of Clinical Pharmacology, 1981, v. 11, n. 3, p. 305, doi. 10.1111/j.1365-2125.1981.tb00539.x
- Baker, JR;
- Peck, CC;
- Raybuck, BD;
- Owens, EL;
- Schuster, BG
- Article